News

New research publication: First-in-class trispecific VHH-Fc based antibody with potent prophylactic and therapeutic efficacy against SARS-CoV-2 and variants|
New research partnership with China Resources Biopharmaceutical

Technology

Computer Aided Antibody Design (Caad)

Traditional Technologies Hybridoma

Traditional Technologies Phage Display

Platform

Imbalanced Bispecific Antibodies
Bispecific antibodies with computationally optimized differential binding affinities, biochemical and biophysical features, and a common light chain.

T cell engager bispecific antibodies

Bispecifics against a CSA & CAA

Bispecifics against a CNS target and a BBB (blood brain barrier) target

Development of a novel "imbalanced" CSA bispecific antibody by computational design

Case Study

Bispecifics involving CD3 binders

Development of Multi-Specific Antibodies by computational design

Case Study

Start from unknown target antigen

Start from known target antigen

Unique feature of second strategy: Screening internalization caused by primary Ab.

Ab Studio's Internalizing Antibody Case Study: Antibody Against Cancer Antigen-X

Case Study

3541 Investment Blvd. Suite 3,
Hayward, CA 94545 USA